Robert R Recker Selected Research

blosozumab

9/2015	The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.
2/2015	A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert R Recker Research Topics

Disease

45	Osteoporosis 01/2023 - 01/2002
13	Postmenopausal Osteoporosis 01/2014 - 03/2005
8	Bone Resorption 01/2022 - 08/2005
7	Obesity 08/2009 - 01/2003
4	Metabolic Bone Diseases (Osteopenia) 09/2015 - 05/2010
4	Neoplasms (Cancer) 11/2013 - 06/2007
3	Breast Neoplasms (Breast Cancer) 09/2011 - 01/2011
2	Wounds and Injuries (Trauma) 01/2022 - 07/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012 - 01/2010
2	Carcinogenesis 05/2011 - 01/2011
1	Vitamin D Deficiency 12/2017
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2017
1	Osteoporosis-pseudoglioma syndrome 01/2017
1	Injection Site Reaction 02/2015
1	Oncogenic osteomalacia 11/2013
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 11/2013
1	Hypophosphatemia 11/2013
1	Anorexia Nervosa 08/2012
1	Atrial Fibrillation 07/2012
1	Esophageal Neoplasms (Esophageal Cancer) 07/2012
1	Ductal Carcinoma 05/2011
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2011
1	Primary Myelofibrosis (Myelosclerosis) 03/2010
1	Osteoporotic Fractures 03/2007
1	Body Weight (Weight, Body) 04/2004
1	Alzheimer Disease (Alzheimer's Disease) 08/2002

Drug/Important Bio-Agent (IBA)

14	Teriparatide (Parathar)FDA Link 01/2023 - 08/2009
12	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2005
11	Diphosphonates (Bisphosphonates)IBA 07/2012 - 03/2005
7	Denosumab FDA Link 01/2023 - 01/2009
7	Ibandronic Acid (Boniva)FDA Link 03/2010 - 03/2005
5	Raloxifene Hydrochloride (Evista)FDA Link 09/2011 - 08/2002
4	CalciumIBA 01/2022 - 06/2007
4	MicroRNAs (MicroRNA)IBA 01/2014 - 01/2011
3	Zoledronic Acid (Zometa)FDA Link 01/2016 - 01/2008
3	Type II Tumor Necrosis Factor ReceptorsIBA 09/2008 - 01/2006
2	Vitamin D FDA LinkGeneric 12/2017 - 06/2007
2	Low Density Lipoprotein Receptor-Related Protein-5IBA 01/2017 - 10/2006
2	blosozumabIBA 09/2015 - 02/2015
2	Monoclonal AntibodiesIBA 02/2015 - 01/2009
2	Phosphates (Orthophosphate)IBA 11/2013 - 07/2010
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 05/2012 - 04/2007
2	Risedronic Acid (Actonel)FDA LinkGeneric 05/2012 - 03/2005
2	ProteomeIBA 04/2012 - 01/2010
2	Cathepsin KIBA 09/2011 - 05/2010
2	Indicators and Reagents (Reagents)IBA 09/2011 - 03/2007
2	strontium ranelate (protelos)IBA 05/2011 - 08/2009
2	ParaffinIBA 05/2011 - 01/2011
2	Formaldehyde (Formol)FDA Link 05/2011 - 01/2011
2	Estrogen ReceptorsIBA 05/2011 - 01/2011
2	Tamoxifen FDA LinkGeneric 01/2011 - 01/2008
2	MineralsIBA 07/2010 - 08/2009
2	Collagen Type I (Type I Collagen)IBA 03/2008 - 01/2003
2	collagen type I trimeric cross-linked peptideIBA 03/2008 - 08/2005
2	Genetic Markers (Genetic Marker)IBA 08/2005 - 01/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2003 - 01/2003
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 06/2017
1	abaloparatideIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Fibroblast Growth Factor-23IBA 11/2013
1	2,4-thiazolidinedione (thiazolidinedione)IBA 08/2012
1	GlucocorticoidsIBA 08/2012
1	CP 320626IBA 04/2012
1	AmidesIBA 04/2012
1	indoleIBA 04/2012
1	GlycogenIBA 04/2012
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 04/2012
1	Carboxylic AcidsIBA 04/2012
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2011
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2011
1	Estrogen Receptor alphaIBA 05/2011
1	RNA (Ribonucleic Acid)IBA 05/2011
1	CarbonatesIBA 07/2010
1	SaltsIBA 07/2010
1	Phosphorus (Red Phosphorus)IBA 07/2010
1	odanacatibIBA 05/2010
1	Serum-Free Culture MediaIBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Amino Acids FDA Link 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	tiboloneIBA 01/2008
1	ipriflavoneIBA 01/2008
1	25-hydroxyvitamin DIBA 06/2007
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 11/2006
1	Glucose (Dextrose)FDA LinkGeneric 10/2006
1	CholesterolIBA 10/2006
1	DNA (Deoxyribonucleic Acid)IBA 10/2006
1	LeptinIBA 07/2005
1	Leptin ReceptorsIBA 04/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2003
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2003
1	ApolipoproteinsIBA 08/2002

Therapy/Procedure

16	Therapeutics 01/2018 - 01/2002
3	Intravenous Administration 03/2013 - 06/2006
3	Injections 03/2010 - 06/2006
2	Subcutaneous Injections 05/2011 - 08/2009
1	Radiotherapy 11/2013
1	Duration of Therapy 09/2011
1	Estrogen Replacement Therapy 08/2011
1	Intravenous Infusions 01/2008